We are live on ! Find out more
BAMS

Bellevue Asset Management (Switzerland) Portfolio holdings

AUM $656M
1-Year Est. Return 11.45%
This Fund
S&P 500
This Quarter Est. Return
+10.91%
1 Year Est. Return
+11.45%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$656M
AUM Growth
+$43.2M
Cap. Flow
-$10.7M
Cap. Flow %
-1.63%
Top 10 Hldgs %
31%
Holding
140
New
7
Increased
40
Reduced
26
Closed
13

Top Buys

Rank Stock Value
1
CAH icon
Cardinal Health
CAH
+$7.77M
2
CNC icon
Centene
CNC
+$5.07M
3
LCI
Lannett Company, Inc.
LCI
+$4.41M
4
VTRS icon
Viatris
VTRS
+$4.34M
5
CVS icon
CVS Health
CVS
+$4.04M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$13.6M
2
RDY icon
Dr. Reddy's Laboratories
RDY
+$8.31M
3
KITE
Kite Pharma, Inc.
KITE
+$7.43M
4
THC icon
Tenet Healthcare
THC
+$3.82M
5
ABT icon
Abbott
ABT
+$3.6M

Sector Composition

Rank Sector Weight
1 Healthcare 93.1%
2 Financials 1.62%
3 Industrials 0.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CELG
1
DELISTED
Celgene Corp
CELG
$26M 3.97%
217,410
-12,350
-5% -$1.43M
BIIB icon
2
Biogen
BIIB
$30.5B
$25.7M 3.92%
84,030
+12,260
+17% +$3.52M
GILD icon
3
Gilead Sciences
GILD
$164B
$24.3M 3.7%
240,120
-13,930
-5% -$1.45M
AMGN icon
4
Amgen
AMGN
$220B
$20M 3.04%
123,000
+3,000
+3% +$472K
REGN icon
5
Regeneron Pharmaceuticals
REGN
$79.1B
$19.8M 3.01%
36,400
-2,500
-6% -$1.35M
MDT icon
6
Medtronic
MDT
$110B
$19.7M 3.01%
256,500
-13,500
-5% -$1.02M
ILMN icon
7
Illumina
ILMN
$30.2B
$17.5M 2.67%
93,985
+3,906
+4% +$630K
ABT icon
8
Abbott
ABT
$183B
$17.1M 2.61%
381,500
-81,500
-18% -$3.6M
VTRS icon
9
Viatris
VTRS
$20.6B
$17M 2.6%
315,300
+90,300
+40% +$4.34M
BDX icon
10
Becton Dickinson
BDX
$47B
$16.2M 2.47%
107,702
+13,089
+14% +$1.88M
CAH icon
11
Cardinal Health
CAH
$56B
$15.3M 2.33%
171,480
+91,480
+114% +$7.77M
UNH icon
12
UnitedHealth
UNH
$375B
$14.1M 2.15%
120,000
– –
SYK icon
13
Stryker
SYK
$129B
$13.1M 1.99%
140,700
– –
TEVA icon
14
Teva Pharmaceuticals
TEVA
$40.5B
$11.6M 1.77%
176,720
+7,500
+4% +$463K
ESRX
15
DELISTED
Express Scripts Holding Company
ESRX
$10.8M 1.65%
124,000
-36,000
-23% -$3.08M
ENDP
16
DELISTED
Endo International plc
ENDP
$10.5M 1.6%
171,000
+13,000
+8% +$790K
CYTO
17
DELISTED
Altamira Therapeutics Ltd
CYTO
$10.4M 1.59%
27
– –
ZBH icon
18
Zimmer Biomet
ZBH
$19B
$9.8M 1.49%
98,365
– –
ALXN
19
DELISTED
Alexion Pharmaceuticals
ALXN
$9.42M 1.44%
49,400
– –
CVS icon
20
CVS Health
CVS
$126B
$9.4M 1.43%
96,200
+41,200
+75% +$4.04M
LGND icon
21
Ligand Pharmaceuticals
LGND
$6.06B
$8.85M 1.35%
130,869
-22,586
-15% -$1.39M
INCY icon
22
Incyte
INCY
$24.3B
$8.57M 1.31%
79,000
+2,000
+3% +$223K
IONS icon
23
Ionis Pharmaceuticals
IONS
$9.01B
$8.55M 1.3%
138,000
+6,000
+5% +$324K
BSX icon
24
Boston Scientific
BSX
$69.2B
$8.48M 1.29%
460,000
+60,000
+15% +$1.08M
MCK icon
25
McKesson
MCK
$103B
$8.48M 1.29%
43,000
+2,000
+5% +$378K
1
2 3 4 5

Similar funds

VFAM
Valley Forge Asset Management King Of Prussia, Pennsylvania $645M AUM 5.8% 1-Year Est. Return
MSU
Maple Securities USA Jersey City, New Jersey $672M AUM 1.03% 1-Year Est. Return
PSI
Pinnacle Summer Investments Fairfax, Virginia $678M AUM 9.54% 1-Year Est. Return
SFP
Santa Fe Partners Santa Fe, New Mexico $608M AUM 8.76% 1-Year Est. Return
MCM
Mazama Capital Management Portland, Oregon $544M AUM 9.52% 1-Year Est. Return
NMIS
Northwestern Mutual Investment Services Milwaukee, Wisconsin $525M AUM 2.45% 1-Year Est. Return
SM
Stratton Management King Of Prussia, Pennsylvania $824M AUM 1.55% 1-Year Est. Return
ZAM
Zenit Asset Management Stockholm, Sweden $450M AUM 8.32% 1-Year Est. Return

Bellevue Asset Management (Switzerland)'s Q4 2015 Portfolio in Review

As of Q4 2015, Bellevue Asset Management (Switzerland) held 140 positions worth $656M, up 7% from $613M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Bellevue Asset Management (Switzerland)'s Q4 2015 filing shows 7 new, 40 increased, 26 reduced and 13 closed positions. Its largest new stake was Lannett Company, Inc.: 26,870 shares worth $4.31M. The largest sale was Allergan plc, an estimated $13.6M.

By sector, the portfolio is most concentrated in Healthcare at 93% of assets, up from 92% a quarter earlier, followed by Financials and Industrials.

  • Bellevue Asset Management (Switzerland)'s largest Q4 2015 buy was Lannett Company, Inc.: 26,870 shares worth $4.31M.
  • Bellevue Asset Management (Switzerland) added most to Cardinal Health in Q4 2015, an estimated $7.77M increase.
  • Bellevue Asset Management (Switzerland)'s biggest Q4 2015 reduction was Kite Pharma, Inc., cutting an estimated $7.43M.
  • Bellevue Asset Management (Switzerland) fully exited Allergan plc in Q4 2015, selling an estimated $13.6M.
  • Bellevue Asset Management (Switzerland)'s ten largest holdings make up 31% of its $656M portfolio in Q4 2015.
  • Bellevue Asset Management (Switzerland) opened 7 new positions and closed 13 in Q4 2015.
  • Bellevue Asset Management (Switzerland)'s portfolio value rose 7% quarter-over-quarter to $656M.

Based on Bellevue Asset Management (Switzerland)'s 13F filing for Q4 2015, filed 12 Feb 2016.